US 8946379
Bladder cancer specific ligand peptides
granted A61KA61K38/00A61K47/51
Quick answer
US patent 8946379 (Bladder cancer specific ligand peptides) held by The Regents of the University of California expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K38/00, A61K47/51, A61K47/64, A61K47/66